Related references
Note: Only part of the references are listed.Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
Clinical Overview of MDM2/X-Targeted Therapies
Andrew Burgess et al.
FRONTIERS IN ONCOLOGY (2016)
Role of calcium-binding sites in calcium-dependent membrane association of annexin A4
Yasuhiro Arii et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2015)
Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis
Marcelo Sobral-Leite et al.
BMC MEDICINE (2015)
Evidence for annexin A6-dependent plasma membrane remodelling of lipid domains
Anna Alvarez-Guaita et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Inside the tumor: p53 modulates calcium homeostasis
Carlotta Giorgi et al.
CELL CYCLE (2015)
S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells
Jyoti K. Jaiswal et al.
CELL CYCLE (2015)
Endocrine resistance in breast cancer - An overview and update
Robert Clarke et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Hitting cancers' weak spots: vulnerabilities imposed by p53 mutation
Evrim Gurpinar et al.
TRENDS IN CELL BIOLOGY (2015)
Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation
Yidong Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
STRING v10: protein-protein interaction networks, integrated over the tree of life
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2015)
Annexin A1 Preferentially Predicts Poor Prognosis of Basal-Like Breast Cancer Patients by Activating mTOR-S6 Signaling
Anjana Bhardwaj et al.
PLOS ONE (2015)
Nutlin-3α: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas
Erin K. Crane et al.
PLOS ONE (2015)
Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells
Matthew T. Balmer et al.
CANCER BIOLOGY & THERAPY (2014)
Sphingosine Kinase 1 Isoform-Specific Interactions in Breast Cancer
Daniel Yagoub et al.
MOLECULAR ENDOCRINOLOGY (2014)
S100A11 is required for efficient plasma membrane repair and survival of invasive cancer cells
Jyoti K. Jaiswal et al.
NATURE COMMUNICATIONS (2014)
GeneMANIA Prediction Server 2013 Update
Khalid Zuberi et al.
NUCLEIC ACIDS RESEARCH (2013)
p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
James G. Jackson et al.
CANCER CELL (2012)
The Annexin A2/S100A10 System in Health and Disease: Emerging Paradigms
Nadia Hedhli et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
p14ARF Post-Transcriptional Regulation of Nuclear Cyclin D1 in MCF-7 Breast Cancer Cells: Discrimination between a Good and Bad Prognosis?
Eileen M. McGowan et al.
PLOS ONE (2012)
Estrogen receptor prevents p53-dependent apoptosis in breast cancer
Shannon T. Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Clinical Significance of Annexin A1 Expression in Breast Cancer
Cha Kyong Yom et al.
JOURNAL OF BREAST CANCER (2011)
Evaluation of Cell Cycle Arrest in Estrogen Responsive MCF-7 Breast Cancer Cells: Pitfalls of the MTS Assay
Eileen M. McGowan et al.
PLOS ONE (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Annexin-1 Regulates Growth Arrest Induced by High Levels of Estrogen in MCF-7 Breast Cancer Cells
Emily Zhao-Feng Ang et al.
MOLECULAR CANCER RESEARCH (2009)
The role of annexins in tumour development and progression
S. Mussunoor et al.
JOURNAL OF PATHOLOGY (2008)
Loss of Annexin A1 Expression in Breast Cancer Progression
Ying Cao et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2008)
Ca2+ signalling checkpoints in cancer:: remodelling Ca2+ for cancer cell proliferation and survival
H. Llewelyn Roderick et al.
NATURE REVIEWS CANCER (2008)
Opinion - Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
John Stingl et al.
NATURE REVIEWS CANCER (2007)
Estrogen receptor α inhibits p53-mediated transcriptional repression:: Implications for the regulation of apoptosis
Aejaz Sayeed et al.
CANCER RESEARCH (2007)
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen
Philippe Bertheau et al.
PLOS MEDICINE (2007)
Functional and quantitative proteomics using SILAC
Matthias Mann
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Angiogenesis-associated protein annexin II in breast cancer: Selective expression in invasive breast cancer and contribution to tumor invasion and progression
Meena R. Sharma et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
Annexin A4 self-association modulates general membrane protein mobility in living cells
Alen Piljic et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Estrogen receptor-α binds p53 tumor suppressor protein directly and represses its function
WS Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC)
Shao-En Ong et al.
NATURE PROTOCOLS (2006)
Enforced expression of p14ARF induces p53-dependent cell cycle arrest but not apoptosis
S Gallagher et al.
CELL CYCLE (2005)
AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitecture
C Benaud et al.
JOURNAL OF CELL BIOLOGY (2004)
p53 activation in chronic radiation-treated breast cancer cells: Regulation of MDM2/p14ARF
LQ Xia et al.
CANCER RESEARCH (2004)
Functional expression of the epithelial Ca2+ channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex
SFJ Van de Graaf et al.
EMBO JOURNAL (2003)
Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy
P Bertheau et al.
LANCET (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Induction of apoptosis by cancer chemotherapy
SH Kaufmann et al.
EXPERIMENTAL CELL RESEARCH (2000)
Share Paper
